Elevance Health stock trades at EUR 358.75 with a P/ E of 18.0

Published on 10/08/2026 at 19:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock stood 0.65 percent below its prior close on October 8, 2026. NYSE price was USD 404.16 versus USD 404.31.

Key points in brief

Elevance Health stock was at EUR 358.75 at Lang & Schwarz on October 8, 2026, down 0.65 percent from EUR 361.10.
The NYSE quote stood at USD 404.16, while market capitalization was USD 87.6 billion.
Barclays raised its target from USD 457.00 to USD 469.00 on October 7, 2026.
Elevance Health is scheduled to report results on October 21, 2026.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health stock was trading at EUR 358.75 at Lang & Schwarz on October 8, 2026 at 6:47 p.m. CEST, with a P/E of 18.0. The price was minus 0.65 percent versus the Lang & Schwarz prior close of EUR 361.10.

Euro quote after the Xetra close

The after-hours quote gives German investors a separate view from the primary US listing. Elevance Health's bid was EUR 358.10 and its ask was EUR 359.40 at the same Lang & Schwarz timestamp.

On the NYSE, Elevance Health last stood at USD 404.16 on October 8, 2026, down 0.04 percent from USD 404.31. The primary-market 52-week range was USD 274.84 to USD 436.24, placing the US quote below its yearly high while keeping it above the low.

Market value and trading activity

Elevance Health had a market capitalization of USD 87.6 billion on October 8, 2026. Trading volume reached 213,177 shares against an average volume of 1,190,296 shares, so the session's reported turnover was below its average level.

The quote data show a P/E of 17.97 and a trailing dividend yield of 0.02 percent. The company operates in the healthcare sector and the medical healthcare plans industry, giving the valuation a direct comparison with other managed-care names.

Comparison with peers

Elevance Health: minus 0.65 percent, P/E 18.0, market capitalization USD 87.6 billion
UnitedHealth Group (NYSE, USD): minus 0.97 percent, P/E 23.95, market capitalization USD 338.1 billion
Humana (NYSE, USD): minus 3.21 percent, P/E 36.37, market capitalization USD 46.1 billion

Target and reporting date

As Markets Insider reported on October 7, 2026, Barclays raised its Elevance Health price target from USD 457.00 to USD 469.00 and retained an Overweight rating. The target lies 16.04 percent above the NYSE price of USD 404.16, using the same currency.

StreetAlpha lists October 21, 2026 as Elevance Health's next earnings date. The scheduled report gives the market a fixed point for comparing the current valuation with the company's next published results.

After-hours price and market reference

At EUR 358.75, the Lang & Schwarz quote was EUR 2.35 below its prior close of EUR 361.10 on October 8, 2026. The primary exchange showed USD 404.16 at the latest intraday timestamp, with the two venues presented in their respective currencies.

The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.